These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
509 related articles for article (PubMed ID: 20360395)
1. Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression. Git A; Dvinge H; Salmon-Divon M; Osborne M; Kutter C; Hadfield J; Bertone P; Caldas C RNA; 2010 May; 16(5):991-1006. PubMed ID: 20360395 [TBL] [Abstract][Full Text] [Related]
2. Reproducibility of quantitative RT-PCR array in miRNA expression profiling and comparison with microarray analysis. Chen Y; Gelfond JA; McManus LM; Shireman PK BMC Genomics; 2009 Aug; 10():407. PubMed ID: 19715577 [TBL] [Abstract][Full Text] [Related]
3. Concordance among digital gene expression, microarrays, and qPCR when measuring differential expression of microRNAs. Pradervand S; Weber J; Lemoine F; Consales F; Paillusson A; Dupasquier M; Thomas J; Richter H; Kaessmann H; Beaudoing E; Hagenbüchle O; Harshman K Biotechniques; 2010 Mar; 48(3):219-22. PubMed ID: 20359303 [TBL] [Abstract][Full Text] [Related]
4. Robust global microRNA expression profiling using next-generation sequencing technologies. Tam S; de Borja R; Tsao MS; McPherson JD Lab Invest; 2014 Mar; 94(3):350-8. PubMed ID: 24445778 [TBL] [Abstract][Full Text] [Related]
5. Performance comparison of digital microRNA profiling technologies applied on human breast cancer cell lines. Knutsen E; Fiskaa T; Ursvik A; Jørgensen TE; Perander M; Lund E; Seternes OM; Johansen SD; Andreassen M PLoS One; 2013; 8(10):e75813. PubMed ID: 24116077 [TBL] [Abstract][Full Text] [Related]
6. Comparison of hepatocellular carcinoma miRNA expression profiling as evaluated by next generation sequencing and microarray. Murakami Y; Tanahashi T; Okada R; Toyoda H; Kumada T; Enomoto M; Tamori A; Kawada N; Taguchi YH; Azuma T PLoS One; 2014; 9(9):e106314. PubMed ID: 25215888 [TBL] [Abstract][Full Text] [Related]
7. Measuring microRNAs: comparisons of microarray and quantitative PCR measurements, and of different total RNA prep methods. Ach RA; Wang H; Curry B BMC Biotechnol; 2008 Sep; 8():69. PubMed ID: 18783629 [TBL] [Abstract][Full Text] [Related]
8. A Post-Processing Algorithm for miRNA Microarray Data. Nersisyan S; Shkurnikov M; Poloznikov A; Turchinovich A; Burwinkel B; Anisimov N; Tonevitsky A Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059403 [TBL] [Abstract][Full Text] [Related]
9. Localization- and mutation-dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co-expressed miRNAs located at 14q32.31. Haller F; von Heydebreck A; Zhang JD; Gunawan B; Langer C; Ramadori G; Wiemann S; Sahin O J Pathol; 2010 Jan; 220(1):71-86. PubMed ID: 19768731 [TBL] [Abstract][Full Text] [Related]
10. Comparison of microarray platforms for measuring differential microRNA expression in paired normal/cancer colon tissues. Callari M; Dugo M; Musella V; Marchesi E; Chiorino G; Grand MM; Pierotti MA; Daidone MG; Canevari S; De Cecco L PLoS One; 2012; 7(9):e45105. PubMed ID: 23028787 [TBL] [Abstract][Full Text] [Related]
11. Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays. Wang Y; Barbacioru C; Hyland F; Xiao W; Hunkapiller KL; Blake J; Chan F; Gonzalez C; Zhang L; Samaha RR BMC Genomics; 2006 Mar; 7():59. PubMed ID: 16551369 [TBL] [Abstract][Full Text] [Related]
13. Integration of RNA-Seq data with heterogeneous microarray data for breast cancer profiling. Castillo D; Gálvez JM; Herrera LJ; Román BS; Rojas F; Rojas I BMC Bioinformatics; 2017 Nov; 18(1):506. PubMed ID: 29157215 [TBL] [Abstract][Full Text] [Related]
14. Expression profiling of microRNA using real-time quantitative PCR, how to use it and what is available. Benes V; Castoldi M Methods; 2010 Apr; 50(4):244-9. PubMed ID: 20109550 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. Baffa R; Fassan M; Volinia S; O'Hara B; Liu CG; Palazzo JP; Gardiman M; Rugge M; Gomella LG; Croce CM; Rosenberg A J Pathol; 2009 Oct; 219(2):214-21. PubMed ID: 19593777 [TBL] [Abstract][Full Text] [Related]
16. Parallel comparison of Illumina RNA-Seq and Affymetrix microarray platforms on transcriptomic profiles generated from 5-aza-deoxy-cytidine treated HT-29 colon cancer cells and simulated datasets. Xu X; Zhang Y; Williams J; Antoniou E; McCombie WR; Wu S; Zhu W; Davidson NO; Denoya P; Li E BMC Bioinformatics; 2013; 14 Suppl 9(Suppl 9):S1. PubMed ID: 23902433 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA Expression Analysis: Next-Generation Sequencing. Liu P Methods Mol Biol; 2018; 1783():171-183. PubMed ID: 29767362 [TBL] [Abstract][Full Text] [Related]
18. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mattie MD; Benz CC; Bowers J; Sensinger K; Wong L; Scott GK; Fedele V; Ginzinger D; Getts R; Haqq C Mol Cancer; 2006 Jun; 5():24. PubMed ID: 16784538 [TBL] [Abstract][Full Text] [Related]
19. Next-Generation Sequencing for MicroRNA Expression Profile. Hu Y; Lan W; Miller D Methods Mol Biol; 2017; 1617():169-177. PubMed ID: 28540684 [TBL] [Abstract][Full Text] [Related]